Research & Development: Page 33

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Transforming Clinical Development with AI

    Applications in Imaging and Performance Risk Management The pharmaceutical industry and regulators alike have acknowledged for some time that the clinical development process is in need of an overhaul. Companies must find a way to innovate more efficiently to meet market demands and remain compet...

    By Chris Porter • Oct. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    AI and Healthcare: From Potential to Powerful Solutions

    In recent years, healthcare and pharma companies have been increasingly investing in the promise of artificial intelligence (AI), machine learning (ML), and other smart technologies. It’s estimated that the global market for AI healthcare will grow to as much as $27.6 billion by 2025.1 This growt...

    By Dr. Harietta Eleftherochorinou • Oct. 1, 2019
  • cancer healthcare Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Oncology

    As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Microbes As Therapies

    While microbiome research is still in its infancy, interest and investment in this field of research has grown quickly. Efforts are ongoing to study how changes in the human microbiome can impact our health. Trillions of microbes — including bacteria, fungi, and viruses — call us home. These bact...

    By Denise Myshko • Oct. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Blockchain Movement

    The pharmaceutical industry is actively exploring blockchain technology — a digital ledger system for records and log transactions — for a number of uses. Experts discuss applications for the industry. Blockchain, the underlying technology behind bitcoin and other cryptocurrencies, is being explo...

    By Denise Myshko • Oct. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    The Intersection of Physics and Biology Daniel O’Connor, President and CEO of OncoSec, talks about his company’s efforts to develop new technologies to stimulate the body’s immune system to target and attack cancer. It is estimated that there are 1.6 million new cases of solid tumor cancers in th...

    By Daniel O'Connor • Sept. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HealthTech

    New Microscope Reveals Interactions Between Drugs and Receptors Trend Watch: Advances in Healthtech Benefit Oncology, Military Docs, Patients, Drug Delivery, and More Researchers at Case Western Reserve University School of Medicine have used a cryo-electron microscopy technique to observe the in...

    By PharmaVoice Team • Sept. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Artificial Intelligence

    Using AI to Connect Patients To Clinical Trials Trend Watch: AI Advances: From Nutrition Advice to Digital Pathology Ohio-based Deep Lens has developed an AI-enabled digital pathology platform that connects to trusted networks of pharma sponsors, researchers, and care teams, so patients can be ma...

    By PharmaVoice Team • Sept. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Improving Clinical Trials Through Conversations Suzann Johnson, Associate Director of Investigator and Patient Engagement at Janssen, talks about how the company’s HealthCaring Conversations for Clinical Research initiative can improve the clinical trial experience for patients and investigators....

    By Suzann Johnson • Sept. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    SHOWCASE: Big Data: Realizing Big Impacts from Investing in Big Data

    The pharmaceutical industry is investing more and more in big data to transform different parts of the business and bolster pipelines. Investment in big data is expected to grow to $7 billion by the end of 2021, up from $4.7 billion in 2018, comprising spending on hardware, software, and professi...

    By PharmaVoice Team • Sept. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Why Patients Avoid Clinical Trials

    And how big data, analytics, technology and domain expertise can help change the paradigm The pharma industry has a big challenge when it comes to clinical trials, one that continues to hinder the industry’s approach to research. Sponsors want patients to enroll in their trials, but the clinical ...

    By Cynthia Verst • Sept. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    A Framework for Harnessing Big Data in Creative Ideation

    We propose a five-part framework for marketers and advertisers looking to harness the potential of data and creativity in healthcare communications in this era of big data and artificial intelligence. Data and Creativity Big data and its related components, such as AI and deep learning, are big t...

    By Iyiola Obayomi • Sept. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    No Longer Lost in Translation

    Biopharma companies, academia, patient groups, and the NIH are embracing translational medicine to increase the number of drugs that can be successfully brought to market. The current process of translating a new discovery into a therapy is slow and expensive. The average length of time from disc...

    By Denise Myshko • Sept. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Imagine if… When we introduced the PharmaVOICE 100 most inspiring people in the life-sciences industry 15 years ago it began a movement. We sought to capture that intangible measure of a person’s influence: inspiration. And we thought who better to identify these individuals than you, our readers...

    By Taren Grom • Aug. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaVOICE 100 Who's on the List - By Category

    Who’s on the List — 2019 Indexed by Category Commanders & Chiefs Paul Balagot precisioneffect Percival Barretto-Ko Astellas US Udit Batra MilliporeSigma Dan Bradbury Equillium Dr. Pablo Cagnoni Rubius Therapeutics Sharon Callahan TBWA\WorldHealth Dr. Donald Deieso WIRB-Copernicus Group Drew D...

    By PharmaVoice Team • Aug. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Clinical Experts

    These clinical development experts are redefining clinical operations to increase efficiencies, reduce costs and timelines, and improve the safety profiles of bringing new medicines to patients. A Rare Passion for Patients Energetic. Unrelenting. L. Mary Smith, Ph.D. Title: Senior VP, Clinical R&...

    By PharmaVoice Team • Aug. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Trending Now… As we head into the second half of the year (as hard to believe as that is) this is a great time to hit pause and evaluate what’s coming down the pike. In this issue, in particular, we are looking at a couple of areas that will have a lasting impact on the industry. First, this mont...

    By Taren Grom • June 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Upfront

    Merck Debuts Documentary A Touch of Sugar Merck’s documentary film, A Touch of Sugar, debuted during the Tribeca Film Festival in April as a part of the company’s America’s Diabetes Challenge: Get to Your Goals. Narrated by award-winning actress and documentary spokesperson Viola Davis, the film ...

    By PharmaVoice Team • June 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    Colon Cancer Screening without the Prep Alex Ovadia, CEO of Check-Cap, talks about the company’s ingestible imaging capsule-based system for colorectal cancer screening. Colorectal cancer (CRC) — the term referring to both rectal and colon cancers — is the third most common cancer diagnosed in bo...

    By Alex Ovadia • June 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HealthTech

    A Mobile Game That Can Detect Alzheimer’s Risk Trend Watch: From Games to Wrist Bands to at Home Diagnostic Tests, Healthtech Applications Expand Personalized Treatment or Therapy  A specially designed mobile phone game can detect people at risk of Alzheimer’s, according to research from the Univ...

    By PharmaVoice Team • June 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Artificial Intelligence

    IBM to use ML and AI to Diagnose Alzheimer’s Trend Watch: From drug development to diagnoses, pharma uses AI across the spectrum IBM has discontinued the development and sales of its Watson for drug discovery product due to poor financial performance, however, it will continue to serve pharmaceut...

    By PharmaVoice Team • June 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Inspiring Leaders For the past 15 years or so, PharmaVOICE has had the honor of showcasing the Healthcare Businesswomen’s Association’s Rising Stars and more recently the Luminaries as well. These women have been identified by their organizations — which span the breadth of the healthcare ecosyst...

    By Taren Grom • May 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    Plants as Anti-infectives Alexander Huang, President and Chairman of Quellthera, talks about the company’s research on biomimicry of plant immune processes as potential therapeutics for hard-to-treat infections. Infections caused by antibiotic-resistant germs are difficult, and may soon become im...

    By Alexander Huang • May 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HealthTech

    Alexa Goes HIPAA Trend Watch: HIPAA-Compliant Voice Assistants and Clinical Applications An invite-only program from Amazon allows select healthcare groups, including hospitals and health insurers, to develop HIPAA-compliant skills for its voice assistant Alexa. The big change is that Alexa can n...

    By PharmaVoice Team • May 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Artificial Intelligence

    AI-Driven twoXAR and Ono Pharma Collaborate on Drug Discovery Research Trend Watch: Partnerships and Collaborations Advance AI Capabilities Ono Pharmaceutical, a Japanese pharmaceutical research and development company, and twoXAR Inc., an AI-driven biopharmaceutical company, have teamed up to jo...

    By PharmaVoice Team • May 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    SHOWCASE: Connected Health: An Important Tool for Improving Outcomes

    The digital age has put more data and insights into the hands of healthcare professionals and patients. Digital technologies — wireless, electronic, mobile, telehealth — have made connected health possible, with the objective of enhancing patient engagement and ultimately health outcomes. To dete...

    By PharmaVoice Team • May 1, 2019